7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-09-30 2016-06-30 2016-03-31 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 2012-09-30 2012-06-30 2012-03-31 2011-09-30 2011-06-30 2011-03-31 2010-09-30 2010-06-30 2010-03-31 2009-09-30 2008-09-27 2008-06-28 2008-03-29 2007-09-29 2007-06-30 2007-03-31 
      
    		                                                             
      cash flows from operating activities:
    		                                                             
      cash receipts from customers
    		96,878,000,000 95,691,000,000 90,809,000,000 93,457,000,000 90,810,000,000 88,731,000,000 84,997,000,000 85,164,000,000 84,733,000,000 87,769,000,000 87,798,000,000 78,267,000,000 83,626,000,000 77,577,000,000 74,192,000,000 75,115,000,000 72,483,000,000 70,134,000,000 66,487,000,000 68,773,000,000 66,336,000,000 65,467,000,000 63,751,000,000 63,874,000,000 63,711,000,000 61,935,000,000 58,873,000,000 44,298,000,000 44,608,000,000 43,369,000,000 44,712,000,000 44,430,000,000 43,913,000,000 44,221,000,000 42,842,000,000 41,482,000,000 37,310,000,000 36,444,000,000 34,570,000,000 32,884,000,000 32,427,000,000 30,505,000,000 28,962,000,000 28,428,000,000 28,018,000,000 26,819,000,000 28,437,000,000 29,207,000,000              
      cash paid for inventory, prescriptions dispensed and health services rendered
    		-56,651,000,000 -52,765,000,000 -48,433,000,000 -52,257,000,000 -54,624,000,000 -46,021,000,000 -44,824,000,000 -55,797,000,000                                                      
      insurance benefits paid
    		-29,925,000,000 -30,367,000,000 -28,477,000,000 -29,107,000,000 -27,872,000,000 -27,591,000,000 -24,894,000,000 -22,439,000,000 -20,550,000,000 -21,351,000,000 -19,757,000,000 -18,294,000,000 -17,514,000,000 -17,304,000,000 -16,616,000,000 -16,633,000,000 -15,720,000,000 -15,789,000,000 -15,456,000,000 -14,903,000,000 -13,738,000,000 -12,180,000,000 -14,303,000,000 -13,430,000,000 -12,820,000,000 -13,041,000,000 -12,951,000,000                                   
      cash paid to other suppliers and employees
    		-8,678,000,000 -9,940,000,000 -8,690,000,000 -9,888,000,000 -7,809,000,000 -11,447,000,000 -9,677,000,000 -8,697,000,000 -8,352,000,000 -7,728,000,000 -9,958,000,000 -10,294,000,000 -7,249,000,000 -6,150,000,000 -8,969,000,000 -9,812,000,000 -6,940,000,000 -6,630,000,000 -8,270,000,000 -7,578,000,000 -7,497,000,000 -6,501,000,000 -8,187,000,000 -7,521,000,000 -6,914,000,000 -7,094,000,000 -7,403,000,000 -3,834,000,000 -4,200,000,000 -4,271,000,000 -4,230,000,000 -3,177,000,000 -3,823,000,000 -4,010,000,000 -4,121,000,000 -2,961,000,000 -3,305,000,000 -3,773,000,000 -4,162,000,000 -3,480,000,000 -3,591,000,000 -4,196,000,000 -3,308,000,000 -3,563,000,000 -3,889,000,000   -3,751,000,000   -3,342,000,000 -3,217,000,000 -3,213,000,000 -3,916,000,000 -3,510,900,000 -2,845,600,000 -2,949,400,000 -2,989,100,000 -1,295,800,000 -1,937,700,000 -2,510,000,000 
      interest and investment income received
    		522,000,000 475,000,000 497,000,000 447,000,000 449,000,000 432,000,000 407,000,000 410,000,000 373,000,000 375,000,000 426,000,000 699,000,000 127,000,000 1,000,000 199,000,000 161,000,000 188,000,000 172,000,000 222,000,000 272,000,000 227,000,000 189,000,000 206,000,000 199,000,000 244,000,000 262,000,000 250,000,000                                   
      interest paid
    		-1,045,000,000 -472,000,000 -1,012,000,000 -518,000,000 -999,000,000 -349,000,000 -1,043,000,000 -369,000,000 -918,000,000 -358,000,000 -773,000,000 -303,000,000 -786,000,000 -368,000,000 -782,000,000 -374,000,000 -832,000,000 -387,000,000 -876,000,000 -387,000,000 -1,110,000,000 -279,000,000 -1,128,000,000 -279,000,000 -1,173,000,000 -379,000,000 -1,123,000,000 -1,199,000,000 -15,000,000 -545,000,000 -330,000,000 -211,000,000 -328,000,000 -339,000,000 -237,000,000 -378,000,000 -112,000,000 -224,000,000 -87,000,000 -127,000,000 -227,000,000 -104,000,000 -102,000,000 -163,000,000 -104,000,000   -128,000,000   -150,000,000 -155,000,000 -129,000,000 -155,000,000 -125,400,000 -116,300,000 -142,500,000 -124,600,000 -119,700,000 -91,500,000 -109,700,000 
      income taxes paid
    		-305,000,000 -725,000,000 -138,000,000 -274,000,000 -700,000,000 -666,000,000 -63,000,000 -908,000,000 -837,000,000 -1,704,000,000 -75,000,000 -1,046,000,000 -1,183,000,000 -1,791,000,000 -96,000,000 -798,000,000 -845,000,000 -1,508,000,000 -44,000,000 -564,000,000 -2,135,000,000 -165,000,000 -65,000,000 -512,000,000 -729,000,000 -1,423,000,000 -53,000,000 -560,000,000 -1,298,000,000 -53,000,000 -506,000,000 -1,477,000,000 -57,000,000 -432,000,000 -1,601,000,000 -161,000,000 -678,000,000 -1,563,000,000 -64,000,000 -838,000,000 -1,413,000,000 -70,000,000 -683,000,000 -1,414,000,000 -116,000,000   -28,000,000   -169,000,000 -549,000,000 -1,029,000,000 -207,000,000 -463,400,000 -470,700,000 -774,300,000 -13,600,000 -626,800,000 -662,200,000 -54,600,000 
      net cash from operating activities
    		796,000,000 1,897,000,000 4,556,000,000 1,860,000,000 -745,000,000 3,089,000,000 4,903,000,000 -2,636,000,000 2,716,000,000 5,908,000,000 7,438,000,000 -1,952,000,000 9,123,000,000 5,443,000,000 3,563,000,000 4,005,000,000 5,521,000,000 5,847,000,000 2,892,000,000 3,567,000,000 1,874,000,000 7,119,000,000 3,305,000,000 2,634,000,000 2,928,000,000 5,338,000,000 1,948,000,000 1,097,000,000 2,934,000,000 2,355,000,000 2,611,000,000 1,999,000,000 3,533,000,000 3,925,000,000 1,611,000,000 2,412,000,000 1,820,000,000 1,037,000,000 1,984,000,000 1,645,000,000 897,000,000 2,172,000,000 1,703,000,000 902,000,000 1,640,000,000 923,000,000 1,231,000,000 2,786,000,000 1,962,000,000 1,207,000,000 1,866,000,000 1,292,000,000 652,000,000 1,060,000,000 907,400,000 786,200,000 651,300,000 740,800,000 445,500,000 719,500,000 707,700,000 
      capex
    		-698,000,000 -607,000,000 -743,000,000 -768,000,000 -670,000,000 -638,000,000 -705,000,000 -911,000,000 -545,000,000 -591,000,000 -984,000,000 -688,000,000 -580,000,000 -408,000,000 -1,051,000,000 -597,000,000 -608,000,000 -486,000,000 -829,000,000 -713,000,000 -534,000,000 -448,000,000 -742,000,000 -567,000,000 -601,000,000 -573,000,000 -716,000,000 -540,000,000 -430,000,000 -482,000,000 -524,000,000 -431,000,000 -457,000,000 -505,000,000 -504,000,000 -598,000,000 -548,000,000 -523,000,000 -419,000,000 -545,000,000 -503,000,000 -388,000,000 -526,000,000 -486,000,000 -318,000,000 0 0 -376,000,000 0 0 -309,000,000 -513,000,000 -465,000,000 -401,000,000 -661,200,000 -527,900,000 -555,000,000 -400,300,000 -454,700,000 -466,100,000 -311,900,000 
      free cash flows
    		98,000,000 1,290,000,000 3,813,000,000 1,092,000,000 -1,415,000,000 2,451,000,000 4,198,000,000 -3,547,000,000 2,171,000,000 5,317,000,000 6,454,000,000 -2,640,000,000 8,543,000,000 5,035,000,000 2,512,000,000 3,408,000,000 4,913,000,000 5,361,000,000 2,063,000,000 2,854,000,000 1,340,000,000 6,671,000,000 2,563,000,000 2,067,000,000 2,327,000,000 4,765,000,000 1,232,000,000 557,000,000 2,504,000,000 1,873,000,000 2,087,000,000 1,568,000,000 3,076,000,000 3,420,000,000 1,107,000,000 1,814,000,000 1,272,000,000 514,000,000 1,565,000,000 1,100,000,000 394,000,000 1,784,000,000 1,177,000,000 416,000,000 1,322,000,000 923,000,000 1,231,000,000 2,410,000,000 1,962,000,000 1,207,000,000 1,557,000,000 779,000,000 187,000,000 659,000,000 246,200,000 258,300,000 96,300,000 340,500,000 -9,200,000 253,400,000 395,800,000 
      cash flows from investing activities:
    		                                                             
      proceeds from sales and maturities of investments
    		2,774,000,000 3,332,000,000 3,534,000,000 2,719,000,000 3,216,000,000 2,265,000,000 2,153,000,000 2,182,000,000 1,907,000,000 1,749,000,000 1,891,000,000 1,194,000,000 1,175,000,000 1,790,000,000 2,570,000,000 1,687,000,000 1,612,000,000 1,770,000,000 2,177,000,000 2,677,000,000 1,080,000,000 1,422,000,000 1,288,000,000 1,433,000,000 1,830,000,000 1,800,000,000 1,986,000,000                                   
      purchases of investments
    		-3,859,000,000 -3,634,000,000 -3,552,000,000 -2,514,000,000 -5,896,000,000 -3,236,000,000 -3,545,000,000 -2,418,000,000 -2,126,000,000 -2,141,000,000 -2,358,000,000 -1,307,000,000 -1,429,000,000 -1,536,000,000 -3,474,000,000 -2,546,000,000 -1,847,000,000 -2,439,000,000 -3,131,000,000 -3,262,000,000 -2,689,000,000 -2,153,000,000 -1,535,000,000 -1,523,000,000 -1,949,000,000 -2,015,000,000 -2,047,000,000                                   
      purchases of property and equipment
    		-698,000,000 -607,000,000 -743,000,000 -768,000,000 -670,000,000 -638,000,000 -705,000,000 -911,000,000 -545,000,000 -591,000,000 -984,000,000 -688,000,000 -580,000,000 -408,000,000 -1,051,000,000 -597,000,000 -608,000,000 -486,000,000 -829,000,000 -713,000,000 -534,000,000 -448,000,000 -742,000,000 -567,000,000 -601,000,000 -573,000,000 -716,000,000 -540,000,000 -430,000,000 -482,000,000 -524,000,000 -431,000,000 -457,000,000 -505,000,000 -504,000,000 -598,000,000 -548,000,000 -523,000,000 -419,000,000 -545,000,000 -503,000,000 -388,000,000 -526,000,000 -486,000,000 -318,000,000   -376,000,000   -309,000,000           
      acquisitions
    		-290,000,000 -119,000,000 -20,000,000 -10,000,000 -12,000,000 -48,000,000 -25,000,000 -120,000,000 -18,000,000 -9,380,000,000 -7,094,000,000 -8,000,000 -6,000,000 -118,000,000 -7,000,000 -11,000,000 -27,000,000 -24,000,000 -84,000,000 -38,000,000 -60,000,000 -155,000,000 -613,000,000 -83,000,000 -111,000,000 -126,000,000 -124,000,000                                   
      other
    		-14,000,000 4,000,000 19,000,000 26,000,000 15,000,000 32,000,000 28,000,000 25,000,000 11,000,000 1,000,000 31,000,000 11,000,000 20,000,000 85,000,000 -31,000,000 27,000,000 23,000,000    -1,000,000 1,000,000 5,000,000 26,000,000 2,000,000 4,000,000 10,000,000       -2,000,000 0 -4,000,000                          
      net cash from investing activities
    		-2,087,000,000 -1,024,000,000 -762,000,000 -547,000,000 -3,347,000,000 -1,625,000,000 -2,094,000,000 -1,242,000,000 -771,000,000 -10,362,000,000 -8,514,000,000 -119,000,000 -805,000,000 -2,130,000,000 -1,993,000,000 -1,440,000,000 -847,000,000 -1,107,000,000 -1,867,000,000 -1,234,000,000 -1,370,000,000 -1,333,000,000 -1,597,000,000 -709,000,000 -829,000,000 -910,000,000 -891,000,000 -634,000,000 -621,000,000 -131,000,000 -434,000,000 -620,000,000 -554,000,000 -421,000,000 -598,000,000 -633,000,000 -9,910,000,000 -546,000,000 -544,000,000 -349,000,000 -625,000,000 -2,560,000,000 -529,000,000 -526,000,000 -567,000,000   -443,000,000   -299,000,000 -508,000,000 -483,000,000 -397,000,000 -437,300,000 -410,400,000 -515,900,000 -346,800,000 -346,200,000 -441,700,000 -2,263,800,000 
      cash flows from financing activities:
    		                                                             
      commercial paper borrowings (repayments)
    		-1,793,000,000 1,780,000,000 -859,000,000 1,319,000,000 800,000,000 -2,719,000,000 2,519,000,000                                                       
      proceeds from issuance of long-term debt
    		   2,954,000,000 0   0 0 4,947,000,000 5,951,000,000     0    2,039,000,000 3,973,000,000 0 3,946,000,000 278,000,000    0 0 39,376,000,000    0               0             
      repayments of long-term debt
    		-2,847,000,000 -19,000,000 -743,000,000 -3,067,000,000 -1,669,000,000 -19,000,000 -18,000,000 -432,000,000 -947,000,000 -1,425,000,000 -362,000,000 -16,000,000 -2,666,000,000 -1,515,000,000 -14,000,000 -2,431,000,000 -2,400,000,000 -2,374,000,000 -3,049,000,000 -5,138,000,000 -9,477,000,000 -8,000,000 -1,008,000,000 14,000,000 -6,451,000,000 -1,017,000,000 -882,000,000       -1,606,000,000   -2,348,000,000   -3,045,000,000        -52,000,000   -301,000,000 -351,000,000          
      repurchase of common stock
    		   0 1,000,000 3,000,000 -3,027,000,000 1,000,000 3,000,000 2,000,000 -2,018,000,000 -1,500,000,000 0 0 -2,000,000,000                -400,000,000 -340,000,000 -3,621,000,000 -40,000,000 -1,894,000,000 -2,066,000,000 -937,000,000 -927,000,000 -2,007,000,000 -800,000,000 -1,200,000,000 -801,000,000 -1,524,000,000 -355,000,000 -393,000,000   -810,000,000   -467,000,000 0 -613,000,000 -887,000,000  0   -700,000   
      dividends paid
    		-846,000,000 -866,000,000 -840,000,000 -838,000,000 -837,000,000 -858,000,000 -840,000,000 -779,000,000 -779,000,000 -795,000,000 -779,000,000 -719,000,000 -726,000,000 -740,000,000 -722,000,000 -660,000,000 -659,000,000 -650,000,000 -656,000,000 -644,000,000 -665,000,000 -663,000,000 -652,000,000 -651,000,000 -646,000,000 -657,000,000 -649,000,000 -510,000,000 -510,000,000 -508,000,000 -511,000,000 -512,000,000 -516,000,000 -455,000,000 -459,000,000 -470,000,000 -391,000,000 -395,000,000 -399,000,000 -324,000,000 -322,000,000 -325,000,000 -276,000,000 -276,000,000 -277,000,000   -211,000,000   -171,000,000 -119,000,000 -119,000,000 -122,000,000 -110,100,000 -98,400,000 -86,200,000 -85,900,000 -88,200,000 -92,100,000 -40,300,000 
      proceeds from exercise of stock options
    		117,000,000 47,000,000 144,000,000 19,000,000 114,000,000 25,000,000 203,000,000 35,000,000 122,000,000 24,000,000 96,000,000 41,000,000 162,000,000 51,000,000 297,000,000 109,000,000 110,000,000 118,000,000 212,000,000 15,000,000 83,000,000 12,000,000 154,000,000 27,000,000 72,000,000 10,000,000 101,000,000 84,000,000 23,000,000 107,000,000 125,000,000 68,000,000 121,000,000 83,000,000 30,000,000 92,000,000 66,000,000 85,000,000 126,000,000 112,000,000 112,000,000 154,000,000 122,000,000 159,000,000 150,000,000 159,000,000 240,000,000 278,000,000 77,000,000 157,000,000 107,000,000 26,000,000 48,000,000 97,000,000 145,100,000 34,800,000 108,800,000 170,100,000 121,600,000 174,400,000 56,900,000 
      payments for taxes related to net share settlement of equity awards
    		-20,000,000 -114,000,000 -11,000,000 -4,000,000 -5,000,000 -145,000,000 -31,000,000 -6,000,000 -7,000,000 -134,000,000 -34,000,000 -33,000,000 -8,000,000 -267,000,000 -62,000,000 -7,000,000 -2,000,000 -156,000,000 -3,000,000 -13,000,000 -7,000,000 -52,000,000 -16,000,000 -27,000,000 -5,000,000 -36,000,000 -44,000,000 -2,000,000   -10,000,000 -49,000,000 -11,000,000                             
      net cash from financing activities
    		-1,382,000,000 806,000,000 -2,332,000,000 431,000,000 -1,588,000,000 1,249,000,000 -1,227,000,000 -972,000,000 -2,697,000,000 3,626,000,000 2,726,000,000 -2,187,000,000 -3,218,000,000 -2,461,000,000 -2,650,000,000 -2,831,000,000 -1,967,000,000 -3,314,000,000 -3,244,000,000 -3,735,000,000 -6,117,000,000 -978,000,000 2,675,000,000 -1,440,000,000 -2,968,000,000 -4,258,000,000 816,000,000 -2,693,000,000 -520,000,000 38,140,000,000 -1,786,000,000 -1,502,000,000 -4,133,000,000 -2,442,000,000 -1,666,000,000 -2,460,000,000 9,743,000,000 -761,000,000 -2,406,000,000 -1,775,000,000 -1,423,000,000 -935,000,000 -850,000,000 -751,000,000 -897,000,000   -1,545,000,000   -832,000,000 -912,000,000 -109,000,000 -702,000,000 -564,800,000   -632,400,000 -184,500,000 -176,200,000 1,736,100,000 
      net increase in cash, cash equivalents and restricted cash
    		-2,673,000,000 1,679,000,000 1,462,000,000 1,744,000,000 -5,680,000,000 2,713,000,000 1,582,000,000 -4,850,000,000 -752,000,000 -828,000,000 1,650,000,000 -4,258,000,000    -266,000,000 2,707,000,000 1,426,000,000 -2,219,000,000 -1,402,000,000 -5,613,000,000 4,808,000,000 4,383,000,000 485,000,000 -869,000,000 170,000,000 1,873,000,000 -2,230,000,000 1,793,000,000 40,364,000,000                                
      cash, cash equivalents and restricted cash at the beginning of the period
    		0 0 8,884,000,000 0 0 0 8,525,000,000 0 0 0 13,305,000,000 0 0 0 12,691,000,000 2,913,000,000 0 0 8,130,000,000 0 0 0 5,954,000,000 0 0 0 4,295,000,000 0 0 1,900,000,000                                
      cash, cash equivalents and restricted cash at the end of the period
    		-2,673,000,000 1,679,000,000 10,346,000,000 1,744,000,000 -5,680,000,000 2,713,000,000 10,107,000,000 -4,850,000,000 -752,000,000 -828,000,000 14,955,000,000 -4,258,000,000 5,100,000,000 852,000,000 11,611,000,000 2,647,000,000 2,707,000,000 1,426,000,000 5,911,000,000 -1,402,000,000 -5,613,000,000 4,808,000,000 10,337,000,000 485,000,000 -869,000,000 170,000,000 6,168,000,000 -2,230,000,000 1,793,000,000 42,264,000,000                                
      proceeds from sale of subsidiaries
    		           679,000,000 15,000,000                                                 
      proceeds from issuance of short-term loan
    		       0 0                                                     
      repayment of short-term loan
    		       0 0                                                     
      cash paid for prescriptions dispensed and health services rendered
    		         -51,095,000,000 -50,223,000,000                                                   
      cash paid for inventory and prescriptions dispensed by retail network pharmacies
    		           -50,981,000,000 -47,898,000,000 -46,522,000,000 -44,365,000,000 -43,654,000,000 -42,813,000,000 -40,145,000,000 -39,171,000,000 -42,046,000,000 -40,209,000,000 -39,412,000,000 -36,969,000,000 -39,697,000,000 -39,391,000,000 -34,922,000,000 -35,645,000,000 -37,820,000,000 -36,305,000,000 -36,195,000,000 -37,040,000,000 -37,570,000,000 -36,178,000,000 -35,520,000,000 -35,276,000,000 -35,575,000,000 -31,401,000,000 -29,853,000,000 -28,276,000,000 -26,799,000,000 -26,302,000,000 -23,966,000,000 -23,169,000,000 -22,387,000,000 -22,270,000,000   -22,515,000,000   -17,445,000,000 -17,567,000,000 -17,805,000,000 -17,581,000,000        
      proceeds from sale-leaseback transactions
    		                                    0 9,000,000 25,000,000 323,000,000 0 5,000,000       0 0 11,000,000    245,100,000 127,300,000 64,300,000 5,300,000 13,800,000 13,800,000 9,900,000 
      derivative settlements
    		                   0    0    0 0 446,000,000                      0          
      net decrease in cash, cash equivalents and restricted cash
    		             852,000,000 -1,080,000,000                                               
      net borrowings of short-term debt
    		                  252,000,000    255,000,000                                       
      proceeds from sale of subsidiary
    		                           0 0 725,000,000                0 0 7,000,000              
      net repayments of short-term debt
    		                                                             
      proceeds from sale of subsidiaries and other assets
    		                                                             
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		                                                             
      proceeds from sale of subsidiary and other assets
    		                                                             
      net borrowings (repayments) of short-term debt
    		                          2,285,000,000                                   
      interest received
    		                           212,000,000 144,000,000 50,000,000 5,000,000 4,000,000 6,000,000 5,000,000 4,000,000 5,000,000 6,000,000 6,000,000 3,000,000 5,000,000 3,000,000 3,000,000 3,000,000 1,000,000 1,000,000 1,000,000 0 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,100,000 4,300,000 3,800,000 6,300,000 8,000,000 7,900,000 7,700,000 
      proceeds from sale of property and equipment and other assets
    		                           4,000,000 5,000,000 2,000,000 7,000,000 8,000,000 5,000,000 11,000,000 9,000,000 2,000,000 14,000,000 6,000,000 8,000,000                       
      acquisitions (net of cash acquired) and other investments
    		                           -83,000,000 -205,000,000 -368,000,000 -187,000,000 -205,000,000 -110,000,000 -165,000,000 -117,000,000 -51,000,000 -9,391,000,000 -51,000,000 -61,000,000 -144,000,000 -54,000,000 -2,194,000,000 -54,000,000 -46,000,000 -254,000,000   -74,000,000   -11,000,000     -13,900,000   -19,900,000   
      purchase of available-for-sale investments
    		                           -21,000,000 -18,000,000 -18,000,000    -1,000,000 -3,000,000 -36,000,000 -60,000,000 -11,000,000 -113,000,000 0 -118,000,000 -43,000,000                    
      maturities of available-for-sale investments
    		                           6,000,000 27,000,000 10,000,000 5,000,000                               
      decrease in short-term debt
    		                           0 0 -1,276,000,000   -106,000,000      -185,000,000     -300,000,000 -390,000,000   -750,000,000              
      reconciliation of net income to net cash from operating activities:
    		                                                             
      net income
    		                           1,390,000,000 -2,563,000,000 998,000,000 1,285,000,000 1,098,000,000 953,000,000 1,541,000,000 924,000,000 1,147,000,000 1,247,000,000 1,272,000,000 1,221,000,000 948,000,000 1,246,000,000 1,129,000,000 1,254,000,000 1,121,000,000 956,000,000 1,006,000,000 965,000,000 775,000,000 867,000,000 815,000,000 712,000,000 808,000,000 821,000,000 770,000,000        
      adjustments required to reconcile net income to net cash from operating activities:
    		                                                             
      depreciation and amortization
    		                           620,000,000 647,000,000 644,000,000 615,000,000 623,000,000 619,000,000 611,000,000 619,000,000 617,000,000 532,000,000 488,000,000 490,000,000 477,000,000 488,000,000 477,000,000 461,000,000 449,000,000 502,000,000 443,000,000 431,000,000 423,000,000 407,000,000 391,000,000 374,000,000 370,000,000 368,000,000 358,000,000 300,300,000 310,900,000 310,000,000 299,300,000 301,700,000 308,000,000 208,800,000 
      goodwill impairments
    		                           0                                  
      losses on settlements of defined benefit pension plans
    		                                                             
      stock-based compensation
    		                           62,000,000 55,000,000 55,000,000 65,000,000 53,000,000 55,000,000 59,000,000 50,000,000 57,000,000 87,000,000 44,000,000 44,000,000 44,000,000 42,000,000 35,000,000 35,000,000 32,000,000 34,000,000 33,000,000 28,000,000 36,000,000 35,000,000 29,000,000 36,000,000 37,000,000 38,000,000 37,000,000        
      deferred income taxes and other noncash items
    		                           44,000,000 190,000,000 62,000,000 250,000,000 7,000,000 14,000,000 44,000,000 58,000,000 17,000,000 -190,000,000 37,000,000 -31,000,000 -108,000,000 28,000,000 16,000,000 47,000,000 16,000,000 66,000,000 4,000,000 62,000,000 21,000,000              
      change in operating assets and liabilities, net of effects from acquisitions:
    		                                                             
      accounts receivable
    		                           -666,000,000 -202,000,000 -857,000,000 -166,000,000 -162,000,000 48,000,000 -435,000,000 -148,000,000 -1,131,000,000 -1,319,000,000 -730,000,000 -481,000,000 -1,288,000,000 -445,000,000 -139,000,000 -943,000,000 -462,000,000 -113,000,000   -70,000,000   -423,000,000 -10,000,000 48,000,000 308,000,000 -185,200,000 -341,600,000 165,700,000 -43,800,000 -229,300,000 367,600,000 198,900,000 
      inventories
    		                           103,000,000 -95,000,000 464,000,000 128,000,000 36,000,000 456,000,000 -170,000,000 -256,000,000 89,000,000 -428,000,000 -152,000,000 -313,000,000 -214,000,000 -171,000,000 -64,000,000 -243,000,000 11,000,000 193,000,000   -776,000,000 -268,000,000 70,000,000 514,000,000 -196,000,000 -114,000,000 68,000,000 -577,000,000 -344,000,000 -11,900,000 18,800,000 -142,500,000 -321,000,000 130,100,000 
      other current assets
    		                           161,000,000 -101,000,000 56,000,000 -181,000,000 43,000,000 -74,000,000 172,000,000 -276,000,000 106,000,000 460,000,000 -138,000,000 269,000,000 -86,000,000 -144,000,000 70,000,000 11,000,000 -73,000,000 238,000,000 171,000,000 -32,000,000 286,000,000   -30,000,000 -10,000,000 8,000,000 -39,000,000 19,200,000 -12,600,000 -34,400,000 4,100,000 -1,400,000 900,000 -20,800,000 
      other assets
    		                           10,000,000 -16,000,000 -113,000,000 23,000,000   -33,000,000 -1,000,000 -52,000,000 35,000,000 4,000,000 -52,000,000 4,000,000 16,000,000 -39,000,000 13,000,000 -3,000,000 -135,000,000   -189,000,000   -52,000,000 15,000,000   -4,400,000 -5,200,000 7,200,000 3,100,000 -12,000,000 -23,200,000 10,100,000 
      accounts payable and claims and discounts payable
    		                           794,000,000 1,223,000,000 -178,000,000 150,000,000 719,000,000 -539,000,000 406,000,000 366,000,000 798,000,000 655,000,000 627,000,000 756,000,000 701,000,000 182,000,000 339,000,000 599,000,000 328,000,000 -230,000,000    -6,000,000 187,000,000 535,000,000 174,000,000 -171,000,000 -115,000,000 292,300,000 179,900,000 -353,700,000 -190,900,000   -188,300,000 
      accrued expenses
    		                           -1,484,000,000 -88,000,000 1,231,000,000 325,000,000 -503,000,000 1,848,000,000 1,585,000,000 -249,000,000 741,000,000 764,000,000 -394,000,000 153,000,000 643,000,000 -329,000,000 362,000,000 444,000,000 -517,000,000 105,000,000 -770,000,000 -155,000,000 1,250,000,000 926,000,000 -102,000,000 156,000,000 50,000,000 -282,000,000 -335,000,000 -50,000,000 213,100,000 -226,600,000 -108,000,000 -52,200,000 -287,300,000 -47,800,000 
      other long-term liabilities
    		                           63,000,000   -70,000,000 -13,000,000 154,000,000 44,000,000 -18,000,000 23,000,000 -23,000,000 -21,000,000 -72,000,000 3,000,000 -16,000,000 -14,000,000 25,000,000 0 24,000,000   -14,000,000   -26,000,000 -9,000,000 -38,000,000 6,000,000 44,100,000 -14,800,000 4,500,000 -1,900,000 -9,800,000 14,000,000 5,700,000 
      increase in short-term debt
    		                              -990,000,000   -405,000,000   -1,488,000,000               -468,000,000 1,337,000,000 200,000,000        
      purchase of noncontrolling interest in subsidiary
    		                                 0 0 -39,000,000                          
      payment of contingent consideration
    		                                                             
      effect of exchange rate changes on cash and cash equivalents
    		                                 0 1,000,000 1,000,000 -7,000,000 -4,000,000 3,000,000 -1,000,000   7,000,000                   
      net decrease in cash and cash equivalents
    		                              391,000,000 -123,000,000 -1,154,000,000  -652,000,000 -680,000,000  -274,000,000 -963,000,000               -39,000,000        
      cash and cash equivalents at the beginning of the period
    		                              0 0 3,371,000,000                             
      cash and cash equivalents at the end of the period
    		                              391,000,000 -123,000,000 2,217,000,000                             
      goodwill impairment
    		                              0                               
      loss on early extinguishment of debt
    		                                 101,000,000                            
      maturity of available-for-sale investments
    		                                8,000,000                             
      sales/maturities of available-for-sale investments
    		                                 9,000,000 17,000,000 50,000,000 75,000,000 24,000,000 16,000,000 16,000,000 48,000,000 55,000,000                    
      excess tax benefits from stock-based compensation
    		                                 9,000,000 36,000,000 27,000,000 35,000,000 38,000,000 59,000,000 24,000,000 28,000,000 37,000,000 14,000,000 21,000,000 13,000,000 13,000,000      0 2,000,000 11,000,000        
      net increase in cash and cash equivalents
    		                                         -1,323,000,000 331,000,000 -377,000,000 176,000,000 -590,000,000 -388,000,000 798,000,000 -521,000,000 66,000,000 735,000,000       -238,400,000  101,600,000 180,000,000 
      cash and cash equivalents at beginning of period
    		                                 0 0 2,459,000,000 0 0 2,481,000,000 0 0 4,089,000,000 0 0 1,375,000,000 0 0 1,413,000,000 0 0 1,427,000,000 0 0 1,086,000,000 0 0 0 1,056,600,000 0 0 530,700,000 
      cash and cash equivalents at end of period
    		                                 1,062,000,000 -652,000,000 1,779,000,000 1,646,000,000 -274,000,000 1,518,000,000 -480,000,000 -1,154,000,000 2,766,000,000 331,000,000 -377,000,000 1,551,000,000 -590,000,000 -388,000,000 2,211,000,000 -521,000,000 66,000,000 2,162,000,000 -128,000,000 60,000,000 1,047,000,000 -94,700,000 666,600,000 -202,500,000 818,200,000 -85,200,000 101,600,000 710,700,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                                             
      proceeds from sale of property and equipment
    		                                       1,000,000 2,000,000 5,000,000 2,000,000 6,000,000 5,000,000      12,000,000           
      accounts payable
    		                                              -389,000,000 1,044,000,000              
      purchase of short-term investments
    		                                                             
      maturity of short-term investments
    		                                                1,000,000   0 0 1,000,000        
      deferred income taxes and other non-cash items
    		                                                5,000,000 59,000,000 70,000,000 63,000,000 -22,000,000 2,000,000 9,000,000 32,200,000 -6,500,000 -1,600,000   -20,200,000 
      change in operating assets and liabilities, net of effects of acquisitions:
    		                                                             
      cash receipts from revenues
    		                                                 24,979,000,000 22,971,000,000 22,779,000,000 22,827,000,000 22,918,000,000 17,706,900,000 14,510,500,000 14,482,000,000 16,321,600,000 15,655,700,000 15,753,200,000 12,861,000,000 
      additions to property and equipment
    		                                                   -513,000,000 -465,000,000 -401,000,000 -661,200,000 -527,900,000 -555,000,000 -400,300,000 -454,700,000 -466,100,000 -311,900,000 
      proceeds from sale or disposal of assets
    		                                                   14,000,000 -2,000,000 12,000,000 500,000 4,100,000 4,700,000 4,800,000 18,600,000 72,900,000 13,200,000 
      acquisitions (net of cash acquired) and investments
    		                                                   -133,000,000 -16,000,000 -9,000,000 -17,000,000   15,900,000   -1,975,000,000 
      issuance of long-term debt
    		                                                             
      decrease in long-term debt
    		                                                     -1,000,000        
      cash paid for inventory
    		                                                      -12,700,900,000 -10,296,000,000 -9,968,300,000 -12,459,800,000 -13,175,900,000 -12,350,200,000 -9,486,700,000 
      sale of short-term investments
    		                                                             
      net reduction in short-term debt
    		                                                             
      sale of short-term investment
    		                                                         27,500,000    
      net reductions in short-term debt
    		                                                             
      excess tax benefits from stock based compensation
    		                                                       3,100,000 25,100,000 27,100,000 18,700,000 22,400,000 7,700,000 
      additions to long-term debt
    		                                                          0 5,500,000,000 500,000,000 
      reductions to long-term debt
    		                                                             
      reconciliation of net earnings to net cash from operating activities:
    		                                                             
      net earnings
    		                                                       736,000,000 774,800,000 748,500,000 689,500,000 723,600,000 408,900,000 
      adjustments required to reconcile net earnings to net cash from operating activities:
    		                                                             
      stock based compensation
    		                                                       32,300,000 22,200,000 13,200,000 12,300,000 24,700,000 22,300,000 
      change in operating assets and liabilities, providing/(requiring) cash, net of effects from acquisitions:
    		                                                             
      reductions in long-term debt
    		                                                       -700,000 -700,000 -600,000 -500,000 -502,300,000 -18,300,000 
      reductions in short-term debt
    		                                                       2,000,000      
      net cash (used in)/provided by financing activities
    		                                                       290,800,000      
      sale/(purchase) of short-term investments
    		                                                             
      net (decrease)/increase in cash and cash equivalents
    		                                                             
      (reductions in) additions to short-term debt
    		                                                         -743,100,000    
      cash outflow from hedging activities
    		                                                             
      (reductions in)/additions to short-term debt
    		                                                          -235,400,000   
      net increase/(decrease) in cash and cash equivalents
    		                                                             
      accounts and claims and discounts payable
    		                                                             
      purchase of short-term investment
    		                                                             
      additions to short-term debt
    		                                                            1,230,100,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.